Aimovig (CGRP Monoclonal Antibody) Update

Good news: Amgen/Novartis is offering 2 months of injectable Aimovig to all who qualify (adults with commercial insurance) once a service request form is completed by both the patient and the prescriber office.

To access the patient form that needs to be completed, go here: https://www.aimovighcp.com/-/media/project/aimovighcp/files/service_request_form.ashx

Once this opens, click on the service request form. Complete the top half in full including all your demographics and your insurance information. The insurance information must be filled in-we have been told it is not sufficient to simply fax in a copy of the insurance card. Also you need to sign and date. Electronic signatures are not accepted.

Once completed and signed you can fax to us at 949-861-8719 or send as an attachment to our email info@ocmigraine.org

You will need to call and make arrangement to pay $25.00 as a processing fee to cover our time in completing our part of this form and faxing in and following up when additional information requested.

We recommend an office visit approximately 1 week after your 2nd injection to document efficacy and to help with insurance approval. As long as our office is documenting that we are trying to get insurance, Amgen/Novartis will continue to provide the monthly 70 mg injection at a small copay fee. We are very pleased with the strong commitment that Amgen/Novartis has made to make available this preventive treatment to almost everyone for 1 full year.

You are strongly encouraged to go to www.aimovig.com to learn more about this first CGRP Monoclonal Antibody that has now come to market for the prevention of episodic and chronic migraine.

In good health,

Drs. Susan Hutchinson & Molly Rossknecht
Orange County Migraine & Headache Center
May 28,